All Stories

  1. Early Detection of Chronic Lung Allograft Dysfunction with Spectral and Intrabreath Oscillometry
  2. Radiologist- and computer-based chest imaging quantification at 12 months post transplant correlates with baseline lung allograft dysfunction
  3. Standard pulmonary function tests and respiratory oscillometry patterns in hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
  4. Respiratory oscillometry in individuals with fibrodysplasia ossificans progressiva
  5. Lung transplantation and bone health: A narrative review
  6. Respiratory oscillometry in individuals with fibrodysplasia ossificans progressiva
  7. Pattern Recognition in Intra-Breath Oscillometry Measurements
  8. Quality control in respiratory oscillometry: reproducibility measures ignoring reactance?
  9. Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial
  10. Evaluation and Management of Dyspnea in Hypermobile Ehlers-Danlos Syndrome and Generalized Hypermobility Spectrum Disorder: Protocol for a Pilot and Feasibility Randomized Controlled Trial (Preprint)
  11. Changes in interpretation of spirometry by implementing the GLI 2012 reference equations: impact on patients tested in a hospital-based PFT lab in a large metropolitan city
  12. Deep learning using multilayer perception improves the diagnostic acumen of spirometry: a single-centre Canadian study
  13. Cannabis use and risks of respiratory and all-cause morbidity and mortality: a population-based, data-linkage, cohort study
  14. Conducting Respiratory Oscillometry in an Outpatient Setting
  15. Correlation of respiratory oscillometry with CT image analysis in a prospective cohort of idiopathic pulmonary fibrosis
  16. Chronic lung allograft dysfunction phenotype and prognosis by machine learning CT analysis
  17. Significance of phenotype change after chronic lung allograft dysfunction onset
  18. Sources and composition of metals in indoor house dust in a mid-size Canadian city
  19. Using Automated Radiographic Signatures to Prognosticate Chronic Lung Allograft Dysfunction: What Does the Future Hold?
  20. Exploring the 175-year history of spirometry and the vital lessons it can teach us today
  21. Pulmonary Dysfunction Augmenting Bacterial Aerosols in Leather Tanneries of Punjab, Pakistan
  22. Aerosol generation during pulmonary function testing: Monitoring during different testing modalities
  23. The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction
  24. Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study
  25. Airways flow limitation in symptomatic adult cannabis smokers
  26. Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic
  27. Characterization of Experimental and Clinical Bioaerosol Generation During Potential Aerosol-Generating Procedures
  28. Development of Quality Assurance and Quality Control Guidelines for Respiratory Oscillometry in Clinic Studies
  29. Proteome-wide effects of naphthalene-derived secondary organic aerosol in BEAS-2B cells are caused by short-lived unsaturated carbonyls
  30. Lung function monitoring in the era of respiratory pandemics
  31. Lung transplantation for cystic fibrosis
  32. Extending cytomegalovirus prophylaxis in high‐risk (D+/R−) lung transplant recipients from 6 to 9 months reduces cytomegalovirus disease: A retrospective study
  33. Airway Oscillometry Detects Spirometric-Silent Episodes of Acute Cellular Rejection
  34. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial
  35. Long-term Outcomes of Lung Transplant With Ex Vivo Lung Perfusion
  36. Indoor measurements of air pollutants in residential houses in urban and suburban areas: Indoor versus ambient concentrations
  37. Determinants of Depressive Symptoms at 1 Year Following ICU Discharge in Survivors of ≥ 7 Days of Mechanical Ventilation
  38. Outcomes of telehealth care for lung transplant recipients
  39. Limited Retention of Wildfire‐Derived PAHs and Trace Elements in Indoor Environments
  40. Incidence of primary graft dysfunction after lung transplantation is altered by timing of allograft implantation
  41. A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
  42. Occupational exposure and consequent health impairments due to potential incidental nanoparticles in leather tanneries: An evidential appraisal of south Asian developing countries
  43. Comprehensive outcomes after lung retransplantation: A single‐center review
  44. A 4-Week Model of House Dust Mite (HDM) Induced Allergic Airways Inflammation with Airway Remodeling
  45. Microfluidic lung airway-on-a-chip with arrayable suspended gels for studying epithelial and smooth muscle cell interactions
  46. LC3-Associated Phagocytosis Is Required for Dendritic Cell Inflammatory Cytokine Response to Gut Commensal Yeast Saccharomyces cerevisiae
  47. Development of a Novel Simulation Reactor for Chronic Exposure to Atmospheric Particulate Matter
  48. Syk Regulates Neutrophilic Airway Hyper-Responsiveness in a Chronic Mouse Model of Allergic Airways Inflammation
  49. The RECOVER Program: Disability Risk Groups and 1-Year Outcome after 7 or More Days of Mechanical Ventilation
  50. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation
  51. One-Year Outcomes in Caregivers of Critically Ill Patients
  52. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation
  53. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation
  54. Syk mediates airway contractility independent of leukocyte function
  55. Survival in Sensitized Lung Transplant Recipients With Perioperative Desensitization
  56. Air Pollution and the Development of Posttransplant Chronic Lung Allograft Dysfunction
  57. LAPCs contribute to the pathogenesis of allergen‐induced allergic airway inflammation in mice
  58. The combined effects of physicochemical properties of size-fractionated ambient particulate matter on in vitro toxicity in human A549 lung epithelial cells
  59. Spleen tyrosine kinase inhibition attenuates airway hyperresponsiveness and pollution-induced enhanced airway response in a chronic mouse model of asthma
  60. Comparative cardiopulmonary effects of size-fractionated airborne particulate matter
  61. Spleen Tyrosine Kinase Mediates BEAS-2B Cell Migration and Proliferation and Human Rhinovirus-Induced Expression of Vascular Endothelial Growth Factor and Interleukin-8
  62. HRV Signaling in Airway Epithelial Cells Is Regulated by ITAM-Mediated Recruitment and Activation of Syk
  63. Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation
  64. Oxidative Stress and Nutritional Factors in Hepatitis C Virus–Positive Liver Recipients, Controls, and Hepatitis C Virus–Positive Nontransplant Patients
  65. Hepatic Lipid Peroxidation and Antioxidant Micronutrients in Hepatitis Virus C Liver Recipients With and Without Disease Recurrence
  66. Oxidative Stress and Nutritional Intakes in Lung Patients With Bronchiolitis Obliterans Syndrome
  67. Syk: A Novel Target for Treatment of Inflammation in Lung Disease
  68. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome?
  69. Role of innate immune cells and their products in lung immunopathology
  70. Syk Associates with Clathrin and Mediates Phosphatidylinositol 3-Kinase Activation during Human Rhinovirus Internalization
  71. CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages
  72. Mycobacterium abscessus Infections in Lung Transplant Recipients: The International Experience
  73. Role of Viral Infections in Asthma and Chronic Obstructive Pulmonary Disease
  74. Syk Is Downstream of Intercellular Adhesion Molecule-1 and Mediates Human Rhinovirus Activation of p38 MAPK in Airway Epithelial Cells
  75. CD44 is a phagocytic receptor
  76. Tyrosine phosphatase SHP‐2 regulates IL‐1 signaling in fibroblasts through focal adhesions
  77. Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells
  78. Control of vesicle fusion by a tyrosine phosphatase
  79. Leukocyte elastase induces epithelial apoptosis: role of mitochondial permeability changes and Akt
  80. Oxidative Stress and Acute Lung Injury
  81. The Protein Tyrosine Phosphatase SHP-2 Regulates Interleukin-1-induced ERK Activation in Fibroblasts
  82. Proteases and lung injury
  83. Protein-tyrosine Phosphatase MEG2 Is Expressed by Human Neutrophils
  84. The Epithelial Na+/H+ Exchanger, NHE3, Is Internalized through a Clathrin-mediated Pathway
  85. Proline-rich Motifs of the Na+/H+Exchanger 2 Isoform
  86. The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange
  87. Utility of Bronchoscopy with Bronchoalveolar Lavage in Diagnosing Pulmonary Infection in Hospitalized Patients with Underlying Malignancy
  88. NO3−-induced pH Changes in Mammalian Cells
  89. Community Acquired, Nursing Home Acquired and Hospital Acquired Pneumonia: A Five‐Year Review of the Clinical, Bacteriological and Radiological Characteristics
  90. Ion transport and the function of phagocytic cells
  91. Interim Report on Drug Utilization Review of Community Acquired, Nursing Home Acquired and Nosocomial Pneumonia: Clinical, Bacteriological and Radiological Spectrum
  92. Chronic multifocal osteomyelitis
  93. Impairment of left ventricular diastolic function in systemic lupus erythematosus